These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28953627)

  • 1. Changes in expression of Wnt signaling pathway inhibitors dickkopf-1 and sclerostin before and after total joint arthroplasty.
    Lu K; Li YX; Shi TS; Yu F; Min SC; Qiao L; Li L; Teng HJ; Jiang Q
    Medicine (Baltimore); 2017 Sep; 96(39):e8082. PubMed ID: 28953627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the Wnt-β-catenin signalling antagonists, sclerostin and dickkopf-related protein 1, in chronic periodontitis.
    Napimoga MH; Nametala C; da Silva FL; Miranda TS; Bossonaro JP; Demasi AP; Duarte PM
    J Clin Periodontol; 2014 Jun; 41(6):550-7. PubMed ID: 24576302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women.
    Lim Y; Kim CH; Lee SY; Kim H; Ahn SH; Lee SH; Koh JM; Rhee Y; Baek KH; Min YK; Kim DY; Kim BJ; Kang MI
    Calcif Tissue Int; 2016 Oct; 99(4):350-9. PubMed ID: 27289555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonists of Wnt/β-catenin signalling in the periodontitis associated with type 2 diabetes and smoking.
    Miranda TS; Napimoga MH; Feres M; Marins LM; da Cruz DF; da Silva HDP; Duarte PM
    J Clin Periodontol; 2018 Mar; 45(3):293-302. PubMed ID: 29243300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis.
    Rossini M; Viapiana O; Zanotti R; Tripi G; Perbellini O; Idolazzi L; Bonifacio M; Adami S; Gatti D
    Calcif Tissue Int; 2015 May; 96(5):410-6. PubMed ID: 25694360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
    Belaya ZE; Rozhinskaya LY; Melnichenko GA; Solodovnikov AG; Dragunova NV; Iljin AV; Dzeranova LK; Dedov II
    Osteoporos Int; 2013 Aug; 24(8):2191-9. PubMed ID: 23358608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.
    Simpson CA; Foer D; Lee GS; Bihuniak J; Sun B; Sullivan R; Belsky J; Insogna KL
    Osteoporos Int; 2014 Oct; 25(10):2383-8. PubMed ID: 24927689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Sost/Sclerostin and Dickkopf-1 Augment Intervertebral Disc Structure in Mice.
    Kroon T; Bhadouria N; Niziolek P; Edwards D; Choi R; Clinkenbeard EL; Robling A; Holguin N
    J Bone Miner Res; 2022 Jun; 37(6):1156-1169. PubMed ID: 35278242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone.
    Idolazzi L; Fassio A; Tripi G; Braga V; Viapiana O; Adami G; Rossini M; Gatti D
    Clin Rheumatol; 2017 Apr; 36(4):925-928. PubMed ID: 28054306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
    Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P
    PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
    Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
    Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum and synovial fluid Dickkopf-1 levels with radiographic severity in primary knee osteoarthritis patients.
    Theologis T; Efstathopoulos N; Nikolaou V; Charikopoulos I; Papapavlos I; Kokkoris P; Papatheodorou A; Nasiri-Ansari N; Kassi E
    Clin Rheumatol; 2017 Aug; 36(8):1865-1872. PubMed ID: 28451870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis.
    Gatti D; Viapiana O; Idolazzi L; Fracassi E; Ionescu C; Dartizio C; Troplini S; Kunnathully V; Adami S; Rossini M
    Bone; 2014 Oct; 67():189-92. PubMed ID: 25003812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Levels of Dickkopf-Related Protein 1 Decrease as Measured GFR Declines and Are Associated with PTH Levels.
    Forster CM; White CA; Turner ME; Norman PA; Ward EC; Hopman WM; Adams MA; Holden RM
    Am J Nephrol; 2020; 51(11):871-880. PubMed ID: 33238271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic Analyses of the Sclerostin rs851056 and Dickkopf rs1569198 Polymorphisms in Mexican-Mestizo Postmenopausal Osteoporosis: A Case-Control Study.
    Vazquez-Villegas ML; Rodriguez-Jimenez NA; Contreras-Haro B; Vasquez-Jimenez JC; Perez-Guerrero EE; Moran-Moguel MC; Sánchez-Rodríguez EN; Villagómez-Vega A; Nuño-Arana I; Becerra-Alvarado IN; Rubio-Arellano ED; Nava-Valdivia CA; Ponce-Guarneros JM; Fajardo-Robledo NS; Nava-Zavala AH; Gonzalez-Lopez L; Saldaña-Cruz AM
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):211-217. PubMed ID: 33734895
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis.
    Ueland T; Stilgren L; Bollerslev J
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerostin and DKK1 in primary hyperparathyroidism.
    Viapiana O; Fracassi E; Troplini S; Idolazzi L; Rossini M; Adami S; Gatti D
    Calcif Tissue Int; 2013 Apr; 92(4):324-9. PubMed ID: 23430197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Serum Wnt Antagonist Levels in Patients With Active Acromegaly.
    Chen H; Huang H; Wang Y; Zhang Y; Liu M; Lou Y; Zhang Z; Zhu D; Li P
    Endocr Pract; 2022 May; 28(5):515-520. PubMed ID: 35123069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of DKK-1 and Sclerostin in Subchondral Bone of the Proximal Femoral Heads from Osteoarthritic Hips.
    Zarei A; Hulley PA; Sabokbar A; Javaid MK
    Calcif Tissue Int; 2017 Jun; 100(6):609-618. PubMed ID: 28275825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.